![From left, Mitchel Doktycz, Yutai Kato and Burak Ozpineci have been named ORNL Corporate Fellows. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-10/CorporateFellows_2.jpg?h=937ade26&itok=XFEIkhPQ)
ORNL has named three researchers ORNL Corporate Fellows for their significant career accomplishments and continued leadership in their scientific fields.
ORNL has named three researchers ORNL Corporate Fellows for their significant career accomplishments and continued leadership in their scientific fields.
A multidisciplinary team of scientists at ORNL has applied a laser-interference structuring, or LIS, technique that makes significant strides toward eliminating the need for hazardous chemicals in corrosion protection for vehicles.
Scientists at ORNL and the University of Tennessee, Knoxville, have found a way to simultaneously increase the strength and ductility of an alloy by introducing tiny precipitates into its matrix and tuning their size and spacing.
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
The COHERENT particle physics experiment at the Department of Energy’s Oak Ridge National Laboratory has firmly established the existence of a new kind of neutrino interaction.
In the search to create materials that can withstand extreme radiation, Yanwen Zhang, a researcher at the Department of Energy’s Oak Ridge National Laboratory, says that materials scientists must think outside the box.
OAK RIDGE, Tenn., Feb. 12, 2020 -- Michael Brady, a researcher at the Department of Energy’s Oak Ridge National Laboratory, has been named fellow of the National Association of Corrosion Engineers, or NACE International.
The American Nuclear Society (ANS) has recognized two nuclear researchers, Julie G.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.